.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Nutra’s category mix skewed 66.98% toward Topical and 33.02% toward Capsules, with Topical down 7.07% year over year but up 1.77% month over month, while Capsules fell 15.08% year over year and 24.46% month over month. Average prices moved in the opposite direction of unit momentum: brand-wide pricing rose 6.60% year over year to $44.38, with Topical averaging 45.56 and Capsules at 42.17, and Nutra held rank 3 in Topical within British Columbia. The pattern implies Nutra’s relative stability now depends on Topical’s modest month-over-month uptick offsetting Capsules’ sharp month-over-month contraction, concentrating exposure in a single category where a rank 3 position can buffer a 10.20% brand-level year-over-year decline.
The shifts indicate a defensive tilt toward Topical leadership accompanied by a retreat from Capsules: a 33.02% share anchored to a category with a 24.46% month-over-month slide weakens multi-category reach, while a 1.77% Topical month-over-month gain sustains visibility behind a rank 3 foothold in British Columbia. With Topical pricing at a 3.21 differential to Capsules and brand-wide prices up 6.60% year over year against a 10.20% sales decline, mix and price are outpacing volume, which implies Nutra’s positioning is shifting toward higher-price, Topical-led outcomes that protect rank but compress Capsules-driven breadth.
Competitive Landscape
Nutra sits at #3 in BC Topical in July 2026, improving 1 rank from #4 year over year and climbing 2 positions from #5 three months ago, while also matching its peak rank at #3 in July 2026; in contrast, Wildflower jumped from #5 to #2 year over year with 183.8% sales growth, and Proofly held #1 year over year but with a 6.7% sales decline, indicating Nutra’s upward rank trajectory is tied to outpacing declining leaders and narrowing the gap to faster risers rather than expanding category spend.
Notable Products
CBD/CBG/CBN 1:1:1 Balance Beam Capsules 30-Pack (600mg CBD, 600mg CBG, 600mg CBN) plunged by 77.5% MoM to rank 9 while CBD/CBG 24k Gold Magnesium + Hyaluronic Acid Transdermal Spray (500mg CBD, 50mg CBG, 60ml) fell 59.3% MoM to rank 9, indicating severe demand compression at the tail. In contrast, CBD Peppermint Lavender + MAG + Hyaluronic Acid Balm (3000mg CBD) grew 10.2% MoM and held rank 1 with approximately $64K in July 2026, while CBD Hemp Isolate Capsules 30-Pack (3000mg CBD) declined 16.1% MoM at rank 2, widening the performance gap between the lead topical and the capsule flagship. Four of the top ten are Capsules, yet three capsule SKUs posted double-digit MoM declines of 16.1%, 18.7%, and 19.5%, implying the Capsules family is losing momentum even as the lead Topical expands share. The pattern implies Nutra’s mix is tilting toward topical pain and recovery formats, suggesting commercial focus is migrating from multi-cannabinoid Capsules toward a hero topical that can anchor pricing and merchandising.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
